Antares Ex-20 Australian Equities is an Managed Funds investment product that is benchmarked against ASX Index Small Ordinaries Index and sits inside the Domestic Equity - Micro Cap Index. Think of a benchmark as a standard where investment performance can be measured. Typically, market indices like the ASX200 and market-segment stock indexes are used for this purpose. The Antares Ex-20 Australian Equities has Assets Under Management of 1.54 M with a management fee of 0.85%, a performance fee of 1.01% and a buy/sell spread fee of 0.3%.
August was a disappointing month for the strategy, which delivered a return of -3.1 (net of fees), compared to that of its benchmark at -1.4%. While the market’s return for the month was relatively benign it masked some substantial volatility at a stock specific level in response to the results season outcomes. Over 20 companies in the ASX 200 moved up or down by more than 10% post report release – the highest number we can recall. This was despite limited levels of earnings revisions. Positioning and liquidity seem to be in command of stock prices at present.
Our best contributor for the month was Cochlear (COH), which delivered strong earnings growth as implant surgeries normalised as hospital waiting times globally began to return to pre COVID levels. More encouragingly, the outlook provided by COH was above expectations, even after allowing for a lift in development expenses, while implant surgery into older cohorts was called out as a focus of Sector allocation future growth. Given the importance of social interaction in a healthy aging process, we have been hoping to see this progress.
Medibank (MPL) also performed well in August. Like COH, it recorded a solid profit result, above the market’s expectations. It also showed a strong fourth quarter recovery in new policy additions, indicating the company was putting the operational impacts of last year’s cyber attacks behind it.
TPG Telecom (TPG) also had a good month. It confirmed it was in negotiations with Vocus to sell its fibre network for a sum of approximately $4.1bn. This is a very good price. It also enjoyed the benefit of market leader, Telstra, driving up mobile telephony yields, which it followed.
Detracting from performance were Block Inc (SQ2) and Judo (JDO). Having risen by more than 21% in July, SQ2 shares were sold down in August after reporting its 2Q23 results. This was despite the company exceeding expectations and upgrading full year EBITDA guidance. The decline appears to be driven by the outlook provided by management whereby 3Q23 gross margins were decelerating, as well as overall macroeconomic concerns. A material portion of SQ2’s earnings are exposed to transaction volumes in small and medium sized businesses, which are adversely impacted by a slowdown in US consumer spending.
Product Snapshot
Performance Review
Product Overview
Peer Comparison
Product Details